Recruiting NA INTERVENTIONAL 1-arm NCT07292779

A Prospective Clinical Investigation of DMFI150 for Treating Nasolabial Folds

A Prospective, Clinical Investigation to Evaluate the Performance and Safety of DMFI150 for the Treatment of Nasolabial Folds

Sponsor: Samyang Biopharmaceuticals Corporation

Conditions Nasolabial Folds, Wrinkles

Interventions DMFI150

Updated 2 times since 2026 Last updated: Mar 4, 2026 Started: Nov 24, 2025 Primary completion: Dec 31, 2026 Completion: Dec 31, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Nasolabial Folds, Wrinkles, this trial is actively recruiting participants. The trial is conducted by Samyang Biopharmaceuticals Corporation and has accumulated 2 data snapshots since 2025. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

2 versions recorded

Mar 2026 — Present [monthly]

Recruiting NA
Jan 2026 — Mar 2026 [monthly]

Recruiting NA

First recorded

Nov 2025

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Samyang Biopharmaceuticals Corporation

Data source: Samyang Biopharmaceuticals Corporation

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Marbella, Spain